EWHA WOMANS UNIVERSITY | Undergraduate/Graduate | Undergraduate | College of Pharmacy

Song, Eun Joo Professor

Pharmaceutical Sciences/Industrial Pharmaceutical Science/Division of Pharmacy

Division Chair, Division of Pharmacy/Department Chair, Pharmacy
Science Building C #307
02-3277-3373
Office hours
- 월 17:00-18:00

Research Record

Practical magnetic bead-based capillary electrophoresis with laser-induced fluorescence for detecting endogenous miRNA in plasma Heliyon, 2023, v.9 no.12, e22809
SCIE Scopus dColl.
Structural and functional characterization of USP47 reveals a hot spot for inhibitor design Communications Biology, 2023, v.6 no.1, 970
SCIE Scopus dColl.
The miR-15b-Smurf2-HSP27 axis promotes pulmonary fibrosis Journal of Biomedical Science, 2023, v.30 no.1, 2
SCIE Scopus dColl.
USP35 dimer prevents its degradation by E3 ligase CHIP through auto-deubiquitinating activity Cellular and Molecular Life Sciences, 2023, v.80 no.4, 112
SCIE Scopus dColl.
Ubiquitin–proteasome system as a target for anticancer treatment—an update Archives of Pharmacal Research, 2023, v.46 no.7, 573-597
SCIE Scopus KCI dColl.
Considerations and Suggestions for the Reliable Analysis of miRNA in Plasma Using qRT-PCR GENES, 2022, v.13 no.2, 328
SCIE Scopus dColl.
MicroRNA-101-3p Suppresses Cancer Cell Growth by Inhibiting the USP47-Induced Deubiquitination of RPL11 CANCERS, 2022, v.14 no.4, 964
SCIE Scopus dColl.
The complex of Fas-associated factor 1 with Hsp70 stabilizes the adherens junction integrity by suppressing RhoA activation JOURNAL OF MOLECULAR CELL BIOLOGY, 2022, v.14 no.6, mjac037
SCIE Scopus dColl.
USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1 Cell Death Discovery, 2022, v.8 no.1, 24
SCIE Scopus dColl.
Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntington's disease PROGRESS IN NEUROBIOLOGY, 2021, v.204, 102110
SCIE Scopus dColl.
Screening of miRNAs in plasma as a diagnostic biomarker for cardiac disease based on optimization of extraction and qRT-PCR condition assay through amplification efficiency BMC Biotechnology, 2021, v.21 no.1, 50
SCIE Scopus dColl.
The Multifaceted Roles of USP15 in Signal Transduction International journal of molecular sciences, 2021, v.22 no.9, 0
SCIE Scopus dColl.
UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation Nature Communications, 2021, v.12 no.1, 3291
SCIE Scopus dColl.
A rapid and reliable CE-LIF method for the quantitative analysis of miRNA-497 in plasma and organs and its application to a pharmacokinetic and biodistribution study RSC ADVANCES, 2020, v.10 no.32, 18648-18654
SCIE Scopus dColl.
Accelerated wound healing in diabetic mice by miRNA-497 and its anti-inflammatory activity Biomedicine and Pharmacotherapy, 2020, v.121, 109613
SCIE Scopus dColl.
Assay Systems for Profiling Deubiquitinating Activity International journal of molecular sciences, 2020, v.21 no.16, 0
SCIE Scopus dColl.
Regulation of deubiquitinating enzymes by post-translational modifications International Journal of Molecular Sciences, 2020, v.21 no.11, 4028
SCIE Scopus dColl.
Ribosomal protein S2 interplays with MDM2 to induce p53 Biochemical and Biophysical Research Communications, 2020, v.523 no.2, 0
SCIE Scopus dColl.
USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2 CANCERS, 2020, v.12 no.5
SCIE Scopus dColl.
Ubiquitin–proteasome system (UPS) as a target for anticancer treatment Archives of Pharmacal Research, 2020, v.43 no.11, 1144-1161
SCIE Scopus KCI dColl.
Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability CELL DEATH & DISEASE, 2019, v.10, 570
SCIE Scopus dColl.
Deubiquitinating Enzymes: A Critical Regulator of Mitosis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, v.20 no.23, 5997
SCIE Scopus dColl.
MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-beta receptor I ubiquitination MOLECULAR ONCOLOGY, 2019, v.13 no.12, 2663-2678
SCIE Scopus dColl.
Phosphorylation of USP15 and USP4 Regulates Localization and Spliceosomal Deubiquitination JOURNAL OF MOLECULAR BIOLOGY, 2019, v.431 no.19, 3900-3912
SCIE Scopus dColl.
[학술지논문] Practical magnetic bead-based capillary electrophoresis with laser-induced fluorescence for detecting endogenous miRNA in plasma HELIYON, 2023, v.9 no.12 , 22809-22809
SCIE
[학술지논문] Structural and functional characterization of USP47 reveals a hot spot for inhibitor design COMMUNICATIONS BIOLOGY, 2023, v.6 no.1 , 970-970
SCIE
[학술지논문] The miR-15b-Smurf2-HSP27 axis promotes pulmonary fibrosis JOURNAL OF BIOMEDICAL SCIENCE, 2023, v.30 no.1 , 2-2
SCIE
[학술지논문] USP35 dimer prevents its degradation by E3 ligase CHIP through auto-deubiquitinating activity CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, v.80 no.4 , 112-112
SCIE
[학술지논문] Ubiquitin-proteasome system as a target for anticancer treatment-an update ARCHIVES OF PHARMACAL RESEARCH, 2023, v.46 no.7 , 573-597
SCIE
[학술지논문] Considerations and Suggestions for the Reliable Analysis of miRNA in Plasma Using qRT-PCR GENES, 2022, v.13 no.2 , 328-328
SCIE
[학술지논문] MicroRNA-101-3p Suppresses Cancer Cell Growth by Inhibiting the USP47-Induced Deubiquitination of RPL11 CANCERS, 2022, v.14 no.4 , 964-964
SCIE
[학술지논문] The complex of Fas-associated factor 1 with Hsp70 stabilizes the adherens junction integrity by suppressing RhoA activation JOURNAL OF MOLECULAR CELL BIOLOGY, 2022, v.14 no.6 , 037-037
SCIE
[학술지논문] USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1 Cell Death Discovery, 2022, v.8 no.1 , 24-24
SCIE
[학술지논문] Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntington's disease PROGRESS IN NEUROBIOLOGY, 2021, v.204 no.0 , 102110-102110
SCI
[학술지논문] Evaluation of Pharmacokinetics and Metabolism of Phosphorothioate Antisense Oligonucleotide G3139 in Rat by Capillary Electrophoresis with Laser-Induced Fluorescence NUCLEIC ACID THERAPEUTICS, 2021, v.31 no.4 , 316-320
SCI
[학술지논문] Screening of miRNAs in plasma as a diagnostic biomarker for cardiac disease based on optimization of extraction and qRT-PCR condition assay through amplification efficiency BMC BIOTECHNOLOGY, 2021, v.21 no.1 , 50-50
SCIE
[학술지논문] UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation NATURE COMMUNICATIONS, 2021, v.12 no.1 , 3291-3291
SCI
[학술지논문] A rapid and reliable CE-LIF method for the quantitative analysis of miRNA-497 in plasma and organs and its application to a pharmacokinetic and biodistribution study RSC ADVANCES, 2020, v.10 no.32 , 18648-18654
SCIE
[학술지논문] Accelerated wound healing in diabetic mice by miRNA-497 and its anti-inflammatory activity BIOMEDICINE & PHARMACOTHERAPY, 2020, v.121 no.0 , 109613-109613
SCI
[학술지논문] Assay Systems for Profiling Deubiquitinating Activity INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, v.21 no.16 , 5638-5638
SCIE
[학술지논문] Regulation of Deubiquitinating Enzymes by Post-Translational Modifications INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, v.21 no.11 , 4028-4028
SCIE
[학술지논문] Ribosomal protein S2 interplays with MDM2 to induce p53 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, v.523 no.2 , 542-547
SCI
[학술지논문] USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2 CANCERS, 2020, v.12 no.5 , 542-547
SCIE
[학술지논문] Ubiquitin-proteasome system (UPS) as a target for anticancer treatment ARCHIVES OF PHARMACAL RESEARCH, 2020, v.43 no.11 , 1144-1161
SCIE
[학술지논문] Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability CELL DEATH & DISEASE, 2019, v.10 no.1 , 570-570
SCIE
[학술지논문] Deubiquitinating Enzymes: A Critical Regulator of Mitosis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, v.20 no.23 , 5997-5997
SCIE
[학술지논문] MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-beta receptor I ubiquitination Molecular Oncology, 2019, v.13 no.12 , 2663-2678
SCIE
[학술지논문] Phosphorylation of USP15 and USP4 Regulates Localization and Spliceosomal Deubiquitination JOURNAL OF MOLECULAR BIOLOGY, 2019, v.431 no.19 , 3900-3912
SCI

2024-1st
- Honors research
  - Subject No 37803Class No 01
  - 4Year ( 1Credit , 1Hour)
- Pharmaceutical Analysis Ⅰ
  - Subject No 38930Class No 01
  - 2Year ( 3Credit , 3Hour) Mon 3~3 (POSCO552) , Fri 2~2 (POSCO451)
  - Major Requisite
- Pharmaceutical Analysis Ⅰ
  - Subject No 38930Class No 02
  - 2Year ( 3Credit , 3Hour) Mon 2~2 (POSCO451) , Fri 3~3 (POSCO451)
  - Major Requisite
- Introduction to Pharmaceutical Research
  - Subject No 38940Class No 01
  - 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A404)
  - Major Requisite
- Pharmaceutical Instrumental Analysis 강의 계획서 상세보기
  - Subject No 38950Class No 01
  - 3Year ( 3Credit , 3Hour) Mon 5~5 (POSCO555) , Thu 3~3 (POSCO)
- Pharmaceutical Analysis Ⅰ
  - Subject No 39035Class No 01
  - 2Year ( 3Credit , 3Hour) Wed 5~5 (PHM-A100-1) , Thu 2~2 (PHM-A100-1)
  - Major Requisite
- Pharmaceutical Instrumental Analysis 강의 계획서 상세보기
  - Subject No 39055Class No 01
  - 3Year ( 3Credit , 3Hour) Mon 5~5 (POSCO555) , Thu 3~3 (POSCO)
2023-2nd
- Pharmaceutical Analysis II
  - Subject No 33963Class No 02
  - 3Year ( 3Credit , 3Hour) Mon 3~3 (POSCO552) , Wed 3~3 (POSCO462)
  - Major Requisite
- Pharmaceutical Analysis II
  - Subject No 33963Class No 03
  - 3Year ( 3Credit , 3Hour) Mon 2~2 (POSCO552) , Wed 2~2 (POSCO462)
  - Major Requisite
- Pharmaceutical Experiment I 강의 계획서 상세보기
  - Subject No 37105Class No 01
  - 3Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I 강의 계획서 상세보기
  - Subject No 37105Class No 02
  - 3Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I 강의 계획서 상세보기
  - Subject No 37105Class No 03
  - 3Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A300)
  - Major Requisite
- Pharmaceutical Instrumental Analysis 강의 계획서 상세보기
  - Subject No 37130Class No 01
  - 4Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A400) , Wed 5~5 (POSCO462)
- Advanced Pharmacy Practice and Research I 강의 계획서 상세보기
  - Subject No 37154Class No 01
  - 6Year ( 4Credit , 200Hour)
  - Major Requisite
- Advanced Pharmacy Practice and Research Ⅱ 강의 계획서 상세보기
  - Subject No 37155Class No 01
  - 6Year ( 4Credit , 200Hour)
  - Major Requisite
- Advanced Pharmacy Practice and Research Ⅲ 강의 계획서 상세보기
  - Subject No 37156Class No 01
  - 6Year ( 4Credit , 200Hour)
  - Major Requisite
- Honors research
  - Subject No 37803Class No 01
  - 4Year ( 1Credit , 1Hour)
- Pharmaceutical Analysis Ⅱ 강의 계획서 상세보기
  - Subject No 38938Class No 01
  - 2Year ( 3Credit , 3Hour) Tue 4~4 (PHM-A400) , Thu 4~4 (PHM-A400)
  - Major Requisite
2023-1st
- Pharmaceutical Analysis I
  - Subject No 33502Class No 02
  - 3Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A100-1) , Wed 4~4 (PHM-A100-1)
  - Major Requisite
- Pharmaceutical Analysis I
  - Subject No 33502Class No 03
  - 3Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A100-1) , Wed 5~5 (PHM-A100-1)
  - Major Requisite
- Pharmaceutical Experiment I 강의 계획서 상세보기
  - Subject No 37105Class No 01
  - 3Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I 강의 계획서 상세보기
  - Subject No 37105Class No 02
  - 3Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I 강의 계획서 상세보기
  - Subject No 37105Class No 03
  - 3Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A300)
  - Major Requisite
- Honors research
  - Subject No 37803Class No 01
  - 4Year ( 1Credit , 1Hour)
- Pharmaceutical Analysis Ⅰ 강의 계획서 상세보기
  - Subject No 38930Class No 01
  - 2Year ( 3Credit , 3Hour) Tue 3~3 (POSCO367) , Thu 5~5 (PHM-A400)
  - Major Requisite
- Pharmaceutical Analysis Ⅰ 강의 계획서 상세보기
  - Subject No 38930Class No 02
  - 2Year ( 3Credit , 3Hour) Wed 2~2 (POSCO555) , Thu 4~4 (PHM-A100-1)
  - Major Requisite
- Introduction to Pharmaceutical Research 강의 계획서 상세보기
  - Subject No 38940Class No 01
  - 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A404)
  - Major Requisite
2022-2nd
- Pharmaceutical Analysis II
  - Subject No 33963Class No 02
  - 3Year ( 3Credit , 3Hour) Mon 2~2 (PHM-A100-1) , Wed 3~3 (PHM-A100-1)
  - Major Requisite
- Pharmaceutical Analysis II
  - Subject No 33963Class No 03
  - 3Year ( 3Credit , 3Hour) Mon 5~5 (POSCO552) , Wed 4~4 (PHM-A100-1)
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 01
  - 3Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 02
  - 3Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 03
  - 3Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A300)
  - Major Requisite
- Pharmaceutical Instrumental Analysis
  - Subject No 37130Class No 01
  - 4Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A404) , Tue 2~2 (PHM-A104)
- Advanced Pharmacy Practice and Research Ⅲ
  - Subject No 37156Class No 01
  - 6Year ( 4Credit , 200Hour)
  - Major Requisite
- Honors research
  - Subject No 37803Class No 01
  - 4Year ( 1Credit , 1Hour)
- Lab rotation Ⅰ
  - Subject No 38927Class No 01
  - 1Year ( 1.5Credit , 0Hour) Thu 7~7
- Lab rotation Ⅰ
  - Subject No 38927Class No 02
  - 1Year ( 1.5Credit Thu 7~7
- Lab rotation Ⅰ
  - Subject No 39032Class No 01
  - 1Year ( 1.5Credit , 0Hour) Thu 7~7
2022-1st
- Pharmaceutical Analysis I
  - Subject No 33502Class No 02
  - 3Year ( 3Credit , 3Hour) Wed 3~3 (PHM-A104) , Fri 3~3 (POSCO152)
  - Major Requisite
- Pharmaceutical Analysis I
  - Subject No 33502Class No 03
  - 3Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A400) , Wed 4~4 (PHM-A104)
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 01
  - 3Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 02
  - 3Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 03
  - 3Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A300)
  - Major Requisite
- Seminar for Pharmaceutical Sciences III
  - Subject No G16849Class No 01
  - Year ( 3Credit , 3Hour) Thu 7~8 (-)
- Seminar for Pharmaceutical Sciences Ⅲ
  - Subject No G18240Class No 01
  - Year ( 3Credit , 3Hour) Thu 7~8 (-)
2021-2nd
- Pharmaceutical Analysis II
  - Subject No 33963Class No 03
  - 3Year ( 3Credit , 3Hour) Mon 3~3 , Wed 3~3
  - Major Requisite
- Pharmaceutical Analysis II
  - Subject No 33963Class No 04
  - 3Year ( 3Credit , 3Hour) Mon 3~3 , Wed 3~3
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 01
  - 3Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 02
  - 3Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 03
  - 3Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 04
  - 3Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A300)
  - Major Requisite
- Pharmaceutical Instrumental Analysis
  - Subject No 37130Class No 01
  - 4Year ( 3Credit , 3Hour) Mon 4~4 , Thu 3~3
- Pharmaceutical Instrumental Analysis
  - Subject No 37130Class No 02
  - 4Year ( 3Credit , 3Hour) Tue 5~5 , Thu 4~4
- Advanced Pharmacy Practice and Research Ⅲ
  - Subject No 37156Class No 01
  - 6Year ( 4Credit
  - Major Requisite
- Honors research
  - Subject No 37803Class No 01
  - 4Year ( 1Credit , 1Hour)
2021-1st
- Pharmaceutical Analysis I
  - Subject No 33502Class No 02
  - 3Year ( 3Credit , 3Hour) Mon 2~2 , Wed 3~3
  - Major Requisite
- Pharmaceutical Analysis I
  - Subject No 33502Class No 03
  - 3Year ( 3Credit , 3Hour) Mon 3~3 , Wed 2~2
  - Major Requisite
- Pharmaceutical Analysis I
  - Subject No 33502Class No 04
  - 3Year ( 3Credit , 3Hour) Mon 2~2 , Wed 3~3
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 01
  - 3Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 02
  - 3Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A300)
  - Major Requisite
- Pharmaceutical Experiment I
  - Subject No 37105Class No 03
  - 3Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A300)
  - Major Requisite
- Honors research
  - Subject No 37803Class No 01
  - 4Year ( 1Credit , 1Hour)

Academic Background

Ewha Womans University 약학박사(분자생명과학부)

Ewha Womans University 약학석사(약학과)

Ewha Womans University 약학사(약학과)

List

College of Pharmacy

Song, Eun Joo Professor

Research Record

Courses

Academic Background